Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (5 T32 AI 125222, 5 T32 AI 125222)
Received: 16 October 2021
Accepted: 17 February 2022
First Online: 5 March 2022
: This study was approved by the Institutional Review Board of the University of California, San Francisco (IRB study approval number 19-27692). The review board waived the requirement for informed consent for this research and none of the patients included were from vulnerable populations.
: Not applicable.
: The authors declare no conflicts of interest.